Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Therapeutic strategies for spinal muscular atrophy: SMN and beyond

Show other versions (1)

Spinal muscular atrophy (SMA) is a devastating neuromuscular disorder characterized by loss of motor neurons and muscle atrophy, generally presenting in childhood. SMA is caused by low levels of the survival motor neuron protein (SMN) due to inactivating mutations in the encoding gene SMN1 A second...

Full description

Bibliographic Details
Main Authors:	Bowerman, M, Becker, C, Yáñez-Muñoz, R, Ning, K, Wood, M, Gillingwater, T, Talbot, K, UK SMA Research Consortium
Format:	Journal article
Language:	English
Published:	Company of Biologists 2017

Similar Items

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM, et al.
Published: (2021)

Spinal muscular atrophy: antisense oligonucleotide therapy opens the door to an integrated therapeutic landscape
by: Wood, M, et al.
Published: (2017)

SMN deficiency disrupts brain development in a mouse model of severe spinal muscular atrophy.
by: Wishart, T, et al.
Published: (2010)

Spinal muscular atrophy.
by: Talbot, K, et al.
Published: (2001)

The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy.
by: Sleigh, J, et al.
Published: (2011)

Targeting the 5' untranslated region of SMN2 as a therapeutic strategy for spinal muscular atrophy
by: Winkelsas, AM
Published: (2020)

Chapter 16 Spinal Muscular Atrophy
by: Talbot, K, et al.
Published: (2003)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022)

Stability and Oligomerization of Mutated SMN Protein Determine Clinical Severity of Spinal Muscular Atrophy
by: Niba, Emma Tabe Eko, et al.
Published: (2022)

A single amino acid residue regulates PTEN-binding and stability of the spinal muscular atrophy protein SMN
by: Rademacher, S, et al.
Published: (2020)

Spinal muscular atrophy: disease mechanisms and therapeutic approaches
by: Meijboom, K
Published: (2018)

Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy.
by: Murray, L, et al.
Published: (2010)

Hepatocyte-intrinsic SMN deficiency drives metabolic dysfunction and liver steatosis in spinal muscular atrophy
by: Leow, Damien Meng-Kiat, et al.
Published: (2024)

Analysis of the survival of motor neuron (SMN1) gene mutations in Spinal Muscular Atrophy through models
by: Owen, N, et al.
Published: (2002)

Infantile spinal muscular atrophy: Therapeutic (R)evolution
by: Daron, A, et al.
Published: (2019)

Reversible molecular pathology of skeletal muscle in spinal muscular atrophy.
by: Mutsaers, C, et al.
Published: (2011)

Spinal muscular atrophy at the crossroads of basic science and therapy
by: Sleigh, J, et al.
Published: (2013)

Spinal muscular atrophy at the crossroads of basic science and therapy.
by: Sleigh, J, et al.
Published: (2013)

Splice-switching therapy for spinal muscular atrophy.
by: Meijboom, K, et al.
Published: (2017)

Chapter 7 Spinal muscular atrophies and hereditary motor neuropathies.
by: Talbot, K, et al.
Published: (2007)

Deletion of smn-1, the Caenorhabditis elegans ortholog of the spinal muscular atrophy gene, results in locomotor dysfunction and reduced lifespan.
by: Briese, M, et al.
Published: (2009)

Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy.
by: Murray, L, et al.
Published: (2010)

Invertebrate models of spinal muscular atrophy: Insights into mechanisms and potential therapeutics
by: Grice, S, et al.
Published: (2011)

Invertebrate models of spinal muscular atrophy: insights into mechanisms and potential therapeutics.
by: Grice, S, et al.
Published: (2011)

High Concentration or Combined Treatment of Antisense Oligonucleotides for Spinal Muscular Atrophy Perturbed SMN2 Splicing in Patient Fibroblasts
by: Wijaya, Yogik Onky Silvana, et al.
Published: (2022)

MOLECULAR ANALYSIS OF CHILDHOOD-ONSET SPINAL MUSCULAR-ATROPHY
by: Theodosiou, A, et al.
Published: (1995)

Modeling spinal muscular atrophy in Drosophila.
by: Chang, H, et al.
Published: (2008)

Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
by: Hammond, S, et al.
Published: (2016)

Spinal muscular atrophies reveal motor neuron vulnerability to defects in ribonucleoprotein handling.
by: Anderson, K, et al.
Published: (2003)

Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice
by: Ahlskog, N, et al.
Published: (2020)

Development Of EZ DNA Diagnostic Kit For The Detection Of Homozygous Deletion Of SMN1 Gene In Spinal Muscular Atrophy (SMA) Patients
by: Marzuki, Marini
Published: (2012)

The spinal muscular atrophy protein SMN affects Drosophila germline nuclear organization through the U body-P body pathway.
by: Lee, L, et al.
Published: (2009)

Alternative splicing events are a late feature of pathology in a mouse model of spinal muscular atrophy.
by: Bäumer, D, et al.
Published: (2009)

Evaluation of cell-penetrating peptide delivery of antisense oligonucleotides for therapeutic efficacy in spinal muscular atrophy
by: Hammond, S, et al.
Published: (2019)

Selective vulnerability of motor neurons and dissociation of pre- and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy.
by: Murray, L, et al.
Published: (2008)

Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen
by: Aragon-Gawinska, K, et al.
Published: (2019)

Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy.
by: Sleigh, J, et al.
Published: (2014)

A novel point mutation in the Caenorhabditis elegans smn-1 gene provides a useful model for investigating Spinal Muscular Atrophy
by: Sleigh, J, et al.
Published: (2010)

Light modulation ameliorates expression of circadian genes and disease progression in spinal muscular atrophy mice
by: Walter, L, et al.
Published: (2018)